Cagrilintide is a long-acting amylin analog that promotes fullness and slows digestion, while Retatrutide is a triple-receptor agonist targeting GLP-1, GIP, and glucagon pathways at once
Breda, P
The rare risk of euglycemic ketoacidosis, while low, is higher in diabetic populations, particularly those also on SGLT2 inhibitors
In addition, patients with major depressive disorder may suffer from either increases or decreases in appetite and weight during a depressive episode (Milaneschi et al., 2019), which is associated with differences in energy metabolism (Simmons et al., 2018) and function of the reward circuit (Kroemer et al., 2022
Am J Transl Res (2023) 15:36372
Elevated insulin levels signal your ovaries to produce excess testosterone